Hims & Hers typically runs video ads on both TV and streaming ... for a specific thing,” he says. The ad, created in-house, relies on dozens of images found via online searches by Hims ...

Most Super Bowl commercials aim to entertain. A minute-long Big Game ad from telehealth company Hims & Hers Health might do something very different. The spot, slated to air during the third quarter ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

In addition to Wegovy, incretin mimetics FDA-approved for ... Research and Manufacturers of America, condemned the ad for misleading consumers about the safety and effectiveness of the compounded ...

reads text in the print ad, above a needle and vial labeled compounded semaglutide. “Bottom line: If the label doesn’t say Wegovy® (semaglutide) or Ozempic® (semaglutide), it’s not FDA ...

In the fourth spot in 2024 was a newcomer to the list, as Novo Nordisk decided to hold off on traditional TV advertising for its obesity juggernaut Wegovy in 2023. That wasn't the case in 2024 ...

Like AbbVie’s duo, Novo Nordisk’s pair of GLP-1 meds also saw their TV ad spending slip in January. Each of the drugs fell three spots from their December seats: Obesity-focused Wegovy took ...

Novo Nordisk, the Fortune 500 Europe company behind weight-loss injection Wegovy (semaglutide), responded Monday with a print ad of its own. “Do you really know what you’re injecting into your body?” ...